ViewRay’s Final Chapter: Liquidation and Delisting Seal Company’s Fate

The curtain is closing on ViewRay as the company enters the final stage of its corporate existence. With the bankruptcy proceedings transitioning to Chapter 7 liquidation, the complete dissolution of the business is now underway. The company’s shares have been relegated to over-the-counter trading, where they’re valued at a mere $0.002.

From Restructuring to Complete Liquidation

What began as a Chapter 11 restructuring effort has now culminated in Chapter 7 liquidation as of October 2023. This procedural shift represents the definitive move away from rehabilitation attempts toward complete corporate dissolution. The company is currently liquidating all remaining assets to satisfy creditor claims while ceasing all business operations entirely.

Final Financial Reporting

Today marks the release of ViewRay’s final quarterly report as an insolvent entity. Investors shouldn’t expect traditional operational metrics or performance indicators. Instead, this concluding financial statement will serve as a liquidation progress report, documenting remaining assets against outstanding liabilities.

Should investors sell immediately? Or is it worth buying ViewRay?

OTC Trading with Minimal Value

Following its removal from the Nasdaq exchange, ViewRay now trades exclusively on the over-the-counter market under the ticker symbol VRAYQ. This market downgrade has resulted in significantly reduced liquidity and diminished market transparency. The current share price of $0.002 underscores the company’s dire financial condition.

• Complete asset liquidation under Chapter 7 bankruptcy
• Over-the-counter trading under symbol VRAYQ
• Share value at $0.002
• Final financial report scheduled for release today

Technical Assessment Points to Total Loss

Technical analysis presents a clear picture: the current signal registers as “Strong Sell.” Moving averages and other technical indicators uniformly reflect the company’s terminal condition. Any position in ViewRay shares must be considered highly speculative with substantial risk of complete capital loss.

ViewRay’s corporate destiny appears sealed. The process now focuses exclusively on monetizing remaining assets for creditor benefit. Shareholders face minimal prospects of recovery as the liquidation process advances toward its conclusion.